quinolinecarboxylicacid,NorfloxacinProperties:
RelatedCategories | AnalyticalStandards,Analytical/Chromatography,EPStandards,EPStandardsN-O,Pharmacopeia&MetrologicalInstitutesStandards |
Description:
Biochem/physiolActions
NorfloxacinblocksDNAreplicationbyinterferingwithanATP-inducedstructuraltransitionofDNAcomplexedwithDNAgyrase(topoisomerase).
Modeofaction:inhibitsbacterialDNAreplication
Antimicrobialspectrum:Gram-negativebacteria;lesseffectiveagainstGram-positivebacteria
Caution
PleasefindSDSprovidedbyEDQMhere..
Generaldescription
ThisproductisprovidedasdeliveredandspecifiedbytheissuingPharmacopoeia.Allinformationprovidedinsupportofthisproduct,includingSDSandanyproductinformationleafletshavebeendevelopedandissuedundertheAuthorityoftheissuingPharmacopoeia.ForfurtherinformationandsupportpleasegotothewebsiteoftheissuingPharmacopoeia.
OtherNotes
Salesrestrictionsmayapply.
Packaging
Unitquantity:10mg.Subjecttochange.TheproductisdeliveredassuppliedbytheissuingPharmacopoeia.Forthecurrentunitquantity,pleasevisittheEDQMreferencesubstancecatalogue.
Safety:
RIDADR
NONHforallmodesoftransport